We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Top Buys

Rank Stock Value
1
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$99.8M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$86.3M
3
DIA icon
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
+$48M
4
IWB icon
iShares Russell 1000 ETF
IWB
+$23M
5
VOO icon
Vanguard S&P 500 ETF
VOO
+$14.3M

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$36.3M
2
EFA icon
iShares MSCI EAFE ETF
EFA
+$31.4M
3
AAPL icon
Apple
AAPL
+$30.2M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$29.6M
5
MSFT icon
Microsoft
MSFT
+$16.2M

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PLRX icon
3601
Pliant Therapeutics
PLRX
$66.9M
$29K ﹤0.01%
1,252
-3,173
-72% -$79.6K
PTEN icon
3602
Patterson-UTI
PTEN
$4.16B
$29K ﹤0.01%
5,508
-182,954
-97% -$719K
REPL icon
3603
Replimune Group
REPL
$1.42B
$29K ﹤0.01%
739
-17,410
-96% -$725K
RNAM
3604
DELISTED
Avidity Biosciences
RNAM
$29K ﹤0.01%
1,118
-1,510
-57% -$44K
UBCP icon
3605
United Bancorp
UBCP
$89.4M
$29K ﹤0.01%
2,179
+1,407
+182% +$17.7K
UFCS icon
3606
United Fire Group
UFCS
$1.38B
$29K ﹤0.01%
1,146
-18,773
-94% -$428K
BIOL
3607
DELISTED
Biolase, Inc.
BIOL
$29K ﹤0.01%
28
+17
+155% +$13K
EMAN
3608
DELISTED
eMagin Corporation
EMAN
$29K ﹤0.01%
17,840
+8,469
+90% +$10.9K
ACOR
3609
DELISTED
Acorda Therapeutics
ACOR
$29K ﹤0.01%
353
+341
+2,842% +$31.4K
RUBY
3610
DELISTED
Rubius Therapeutics, Inc
RUBY
$29K ﹤0.01%
3,843
-30,497
-89% -$181K
ELOX
3611
DELISTED
Eloxx Pharmaceuticals, Inc. Common Stock
ELOX
$29K ﹤0.01%
180
-560
-76% -$68.4K
ANAT
3612
DELISTED
American National Group, Inc. Common Stock
ANAT
$29K ﹤0.01%
305
+48
+19% +$3.87K
PRGX
3613
DELISTED
PRGX Global, Inc.
PRGX
$29K ﹤0.01%
+3,833
New +$23.4K
AUBN icon
3614
Auburn National Bancorp
AUBN
$92.4M
$28K ﹤0.01%
677
-1,674
-71% -$66.5K
AVNW icon
3615
Aviat Networks
AVNW
$282M
$28K ﹤0.01%
+1,640
New +$23.3K
BV icon
3616
BrightView Holdings
BV
$1.08B
$28K ﹤0.01%
1,831
-42,080
-96% -$576K
CHEF icon
3617
Chefs' Warehouse
CHEF
$4.57B
$28K ﹤0.01%
1,103
-25,995
-96% -$511K
CNVS icon
3618
Cineverse
CNVS
$68.2M
$28K ﹤0.01%
+2,140
New +$26K
DGICA icon
3619
Donegal Group Class A
DGICA
$696M
$28K ﹤0.01%
1,987
-8,995
-82% -$129K
DLHC icon
3620
DLH Holdings
DLHC
$68.7M
$28K ﹤0.01%
3,030
+2,067
+215% +$19.4K
FTHM icon
3621
Fathom Holdings
FTHM
$24.5M
$28K ﹤0.01%
775
+44
+6% +$1.06K
HTGC icon
3622
Hercules Capital
HTGC
$3.17B
$28K ﹤0.01%
1,952
+1,903
+3,884% +$24.2K
ICAD
3623
DELISTED
iCAD Inc
ICAD
$28K ﹤0.01%
2,143
-16,801
-89% -$181K
KC
3624
Kingsoft Cloud Holdings
KC
$3.42B
$28K ﹤0.01%
640
-16,747
-96% -$620K
MAIN icon
3625
Main Street Capital
MAIN
$5.54B
$28K ﹤0.01%
+877
New +$26.9K
143 144
145
146 147

Similar funds

CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
AP
Altarock Partners West Palm Beach, Florida $4.13B AUM 0.04% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
SP
Stockbridge Partners Boston, Massachusetts $4.14B AUM 16.9% 1-Year Est. Return
GCM
Graham Capital Management Rowayton, Connecticut $4.14B AUM 17.82% 1-Year Est. Return
ZP
Zimmer Partners New York $4.15B AUM 14.2% 1-Year Est. Return

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.